Talzenna .1 mg/1
talazoparib · CAPSULE, LIQUID FILLED · Pfizer Laboratories Div Pfizer Inc
Talzenna (talazoparib) is an oral capsule medication used to treat certain types of cancer in patients with specific genetic mutations. It works by blocking DNA repair mechanisms in cancer cells, making them more vulnerable to damage and death.
Key Facts
- Brand Name
- Talzenna
- Generic Name
- talazoparib
- NDC Code (Product)
0069-0252- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- .1 mg/1
- Dosage Form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Marketing Status
- Application #
- NDA217439
- Marketing Start
- 04/17/2024
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Talzenna used for?
Talzenna (talazoparib) is an oral capsule medication used to treat certain types of cancer in patients with specific genetic mutations. It works by blocking DNA repair mechanisms in cancer cells, making them more vulnerable to damage and death.
Is Talzenna a controlled substance?
Talzenna is not classified as a controlled substance by the DEA.
What is the generic name for Talzenna?
The generic name for Talzenna is talazoparib. There are no other listed brand versions of talazoparib.
What is the NDC code for Talzenna .1 mg/1?
The NDC (National Drug Code) for Talzenna .1 mg/1 is 0069-0252, listed by Pfizer Laboratories Div Pfizer Inc.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)